This episode of “Real-World Data After Dark” features Daniel Chancellor, Dr. Madeline Naylor, and Lance discussing how real-world data (RWD), EMR data, and AI are transforming pharma decision-making and patient care. Through a game-show-style conversation, they explore how integrated datasets and unstructured clinical data help generate real-world evidence, improve patient identification, accelerate therapies to market, and deliver meaningful impact beyond traditional ROI. The episode also highlights the future of predictive analytics and large language models, which could enable earlier disease detection and fundamentally change how patients receive treatment.